Our in vitro results are supported by the co-expression of PTGS2 gene and M2 markers detected in a significant fraction of human thyroid carcinoma, thus highlighting the possibility to counteract tumor growth through COX-2 inhibition. Here, PTGS2 is linked to neoplasm.